Expansion of VIDIA’s production programme (Q10954): Difference between revisions
Jump to navigation
Jump to search
(Removed claim: summary (P836): The project aims at introducing an innovation of the product and technology of production (1) of strip membrane tests for use in the diagnosis of the most frequent zoonotic agents and the most frequent agents of neuroinfections (results of own research funded by R & D) (2) in vitro diagnostics (own research results). Innovation in the 7th order is at European level. This includes organisational innovation consisting of the acquisition of softw...) |
(Created claim: summary (P836): The project aims to introduce innovation of product and production technology 1) strip membrane tests for use in the diagnosis of the most common agents of tick-borne infections and the most common neuroinfectious agents (results of own research funded by the R & D grant) 2) of cluster tests for in vitro diagnostics (results of own research). The 7th-order innovation is at European level. Part of the organisational innovation is the acquisition...) |
||||||||||||||
| Property / summary | |||||||||||||||
The project aims to introduce innovation of product and production technology 1) strip membrane tests for use in the diagnosis of the most common agents of tick-borne infections and the most common neuroinfectious agents (results of own research funded by the R & D grant) 2) of cluster tests for in vitro diagnostics (results of own research). The 7th-order innovation is at European level. Part of the organisational innovation is the acquisition of SW for the control of production and storage with accessories.. a. (English) | |||||||||||||||
| Property / summary: The project aims to introduce innovation of product and production technology 1) strip membrane tests for use in the diagnosis of the most common agents of tick-borne infections and the most common neuroinfectious agents (results of own research funded by the R & D grant) 2) of cluster tests for in vitro diagnostics (results of own research). The 7th-order innovation is at European level. Part of the organisational innovation is the acquisition of SW for the control of production and storage with accessories.. a. (English) / rank | |||||||||||||||
Normal rank | |||||||||||||||
| Property / summary: The project aims to introduce innovation of product and production technology 1) strip membrane tests for use in the diagnosis of the most common agents of tick-borne infections and the most common neuroinfectious agents (results of own research funded by the R & D grant) 2) of cluster tests for in vitro diagnostics (results of own research). The 7th-order innovation is at European level. Part of the organisational innovation is the acquisition of SW for the control of production and storage with accessories.. a. (English) / qualifier | |||||||||||||||
point in time: 22 October 2020
| |||||||||||||||
Revision as of 15:17, 22 October 2020
Project in Czech Republic financed by DG Regio
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Expansion of VIDIA’s production programme |
Project in Czech Republic financed by DG Regio |
Statements
5,594,981.4 Czech koruna
0 references
12,433,292.0 Czech koruna
0 references
45 percent
0 references
7 February 2017
0 references
29 April 2020
0 references
VIDIA spol. s r.o.
0 references
49°59'0.49"N, 14°30'9.11"E
0 references
25250
0 references
Projekt je zaměřen na zavedení inovace produktu a technologie výroby 1) proužkových membránových testů pro použití při diagnostice nejčastějších původců infekcí přenášených klíšťaty a nejčastějších původců neuroinfekcí (výsledky vlastního výzkumu financovaném grantem VaV) 2) kazetových testů pro diagnostiku in vitro (výsledky vlastního výzkumu). Inovace 7. řádu je na úrovni Evropy. Součástí je organizační inovace spočívající v pořízení SW na řízení výroby a skladování s příslušenstvím.. a. (Czech)
0 references
The project aims to introduce innovation of product and production technology 1) strip membrane tests for use in the diagnosis of the most common agents of tick-borne infections and the most common neuroinfectious agents (results of own research funded by the R & D grant) 2) of cluster tests for in vitro diagnostics (results of own research). The 7th-order innovation is at European level. Part of the organisational innovation is the acquisition of SW for the control of production and storage with accessories.. a. (English)
22 October 2020
0 references
Identifiers
CZ.01.1.02/0.0/0.0/16_049/0008884
0 references